Neurological disorders such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and ALS have long been managed with symptomatic treatments that rarely address their root causes. Recent advances in CRISPR gene-editing technology are changing that paradigm, opening the door to targeted therapies that can repair or silence faulty genes at their source.
This course explores the science of CRISPR and its application in neurology, including delivery challenges to the brain and spinal cord, current research breakthroughs, clinical trial data, and the ethical considerations of editing the human genome. Participants will gain a strong foundation in how CRISPR works, the potential benefits and risks of its use in neurological medicine, and the future landscape of gene-based therapies
After watching the presentation head over to my account and complete to the survey to get credit..


